Inbox Report Mr Gregg A Sheehan DOB 24-Apr-1954 Patient: Sheehan, Gregg A DOB: 24 Apr 1954 Subject: Glycated Haemoglobin Date: 01 Oct 2013 Reference: SCL 13-8360776-GLY-0 HDAIc: 35 mmol/mol ( 20 - 40 } Tf used as a screening test, diabetes is virtually excluded Tf diabetic and treated with insulin/sulphonylureas, the risk for hypoglycaemia is increased. HBAlc may be misleading in some situations (e.g haemoglobinopathies, increased red cell turnover or after recent blood transfusion). Glucose-based diagnostic criteria should always be used in situations where HbAic is unreliable. Ordered by: PETER BATTERSBY Laboratory: scl Observation date: 01-Oct-2013 Patient: Sheehan, Gregg A DOB: 24 Apr 1954 ‘Subject: Urine Date: 01 Oct 2013, Reference: SCL 13-8360878-U-0 URINE: MID-STREAM URINE MIcRoscoPy Leucocytes: Nil Red cells: Nil Hyaline Casts: + CHEMISTRY Albumin: Negative Glucose: Negative Specific Gravity: 1.015, bE 5.0 Ketones: + Urine indicators of infection, Qualitative Chemistry (Dipstrip) and Microscopy, are negative therefore this specimen has not been cultured. Please contact the laboratory within 48 hours if culture is required Validated by pL, mused ordered by: PETER BATTERSEY Laboratory: sel Observation date: 01-oct-2013 Patient: Sheehan, Gregg A DOB: 24 Apr 1954 Subject: Iron Studies Date: 01 Oct 2013 Reference: SCL 13-8360776-ISM-0 ee ‘Taupo Medical Centre Page t SH (M) 10-Aug-2015 12:37pmInbox Report Transferrin: ‘Transferrin Saturation: [Mr Gregg A Shoshan DOB 24-Apr-1954 16 mol/L (10 - 30) 655 ug/L ( 20 - 500 ) HH 1.9 g/L (2.0 - 3.5) ob 34% (16 - 50) Normal transferrin saturation usually excludes causes of a high ferritin such as infection, inflammation and hereditary haemochromatosis include liver damage, excess alcohol, hyperthyroidism. Validated by sw, mLSci Ordered by Laboratory: Observation date: Other causes to consider chronic iron ingestion or rarely PETER BATTERSBY scl 01-0ct-2013 Patient: Sheehan, Gregg A Subject: Glucose Master Reference: SCL 13-8360776-GLO-0 Fasting statue: Glucose ordered by: Laboratory: Observation date: Date: 01 Oct 2013 Fasting 5.2 mmol/L (3.5 - 5.4} PETER BATTERSBY sel 01-oct-2013 Patient: Sheehan, Gregg A Subject: Lipids Master Panel Reference: SCL 18-8360776-LPD-0 Fasting status: Cholesterol: Triglyceride: HDL Cholesterol: LDL cholesterol Chol/#DL Rati DOB: 24 Apr 1954 Date: 01 Oct 2013 Fasting 6.6 mmol/L H 4.0 mol/L 1-00 mmol/L & 3.8 mmol/L 66H In established CHD and diabetes targets. account all known risk factors. use optimal levels published by NzGG as Calculation of cardiovascular risk is recommended, taking into For further information see http: //tiny.cc/nzggGuidel ines Highlighted results should be reviewed in the light of the patient's condition and the reasons for testing - including whether testing is being carried out for primary or secondary CHD prevention ordered b; PETER BATTERSBY Laboratory: scl Observation date: 01-oct-2013 Patient: Sheehan, Gregg A Subject: Total Prostatic Spec Ag Reference: SCL 13-8360776-PSA-0 DOB: 24 Apr 1954 Date: 01 Oct 2013 sss SH(M) 10-Au Taupo Medical Centre Page 2Inbox Report Mr Gregg A Sheehan DOB 24-Apr-1956 Total PSA 6 ug/L (00-35) it is advisable when using a tumour marker to monitor patient progress that the same method of analysis is used on each occasion. Ordered by: PETER BATTERSBY Laboratory: scl Observation date: 01-0ct-2013 Patient: Sheehan, Gregg A DOB: 24 Apr 1954 Subject: Thyroid Function Tests Date: 01 Oct 2013, Reference: SCL 13-8360776-TFM-0 TSH: 3.0 mIU/L ( 0.30 - 5.00} Consistent with euthyroidism. Ordered by: PETER BATTERSEY Laboratory: scl Observation dati 01-0ct-2013 Patient: Sheehan, Gregg A DOB: 24 Apr 1954 ‘Subject: Liver Function Panel Date: 01 Oct 2013, Reference: SCL 13-8360776-LF-0 Total Bilirubin: 19 umol/L (2-17) HE Alk. Phosphatase: 79 U/L ( 40 - 170} cor: 21 U/L ( < 56 } ALT: 15 U/l (< 40) ast: 15 U/L ( < 40) Total Protein: 70 g/t ( 64 - 83) Albumin: 44 g/L (35 - 50) Serum Globulin: 26 g/L (18 - a6) ordered by PETER BATTERSBY Laboratory sel Observation date: 01-oct-2013 Patient: Sheehan, Gragg A DOB: 24 Apr 1954 Subject: Quantitative Crp Date: 01 Oct 2013, Reference: SCL 13-8360776-CRP-0 c-Reactive Protein: 3mg/t (<5) ordered by: PETER BATTERSBY Laboratory: scl Observation date: 01-0ct-2013 Patient: Sheehan, Gregg A DOB: 24 Apr 1954 ‘Subject: Renal Function Panel Date: 01 Oct 2013, Reference: SCL 13-8360776-RF-O Taupo Medical Centre Page 3Inbox Report Mr Grogg A Sreshan 008 24-Apr 1054 Sodium: 139 mmol/L (134-446) Potassium: Creatinine: 5.0 mmol/L ( 3 87 umol/L ( 50 0.59 mmol/L ( 0 5 - 5.2) = 120) :12- 0.45 ) He 84 mb/min/1.73m2 Note change to eGFR estimating equation from 25.2.13 The GFR range for a young adult male is 67-167 by approximately 1 mL/min/year. Potassium reference interval is for serum samples. samples may be up to 0.3 mmol/L lower. Ordered by: Laboratory: Observation dat. PETER BATTERSBY scl 01-Oct-2013 From age 30, values fall Potassium in plasma Patient: Sheehan, Gregg A Subject: Complete Bld Count Reference: SCL 13-8360776-FBE-0 DOB: 24 Apr 1954 Date: 01 Oct 2013, Haemoglobin: 149 g/L ( 132 - 170) Pov: 0.45 ( 0.38 - 0.50 ) Nev! 90 £1 ( 80 - 98 ) MCH: 30.0 pg ( 27.0 - 33.0) Platelete: 282 x 1009/L ( 150 - 420 } wee: 7.3 x 10e9/L ( 4.0 - 11.0) Neutrophils 3.8 x 10e9/L ( 2.0 - 7.5) 2.3 x 10e9/L (0.7 - 4.0 } 0.8 x 10e9/L (0.2 - 1.0 } Eosinophil, 0.3 x 10e9/L ( < 0.51 } Basophile: 0.1 x 10e9/L ( < 0.3 ) ordered by: PETER BATTERSBY Laboratory: scl Observation date: 01-0ct-2013 SH (M) 10-Aug-2015 12:37pm ‘Taupo Medical Centre Page 4